Buoyed by promising results of a Phase I study demonstrating the safety of mesenchymal stem cell therapy to treat frailty in older adults, researchers at the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have taken it a step further.
Now Phase II randomized, placebo-controlled trial findings have verified their initial study, boosting the potential for this stem cell therapy to reverse or forestall the symptoms of frailty. Not only is there no currently approved medical therapy for frailty, the need is expected to grow substantially given the overall aging of the U.S. population.
More and more often in this era of big data, it’s not a lack of information that’s the issue. Instead, it can be sorting through a tsunami of data to find what’s most relevant and meaningful to drive medical research forward. Now a $1.4 million grant from the National Institute of Health will boost efforts of a team of researchers at the University of Miami Miller School of Medicine.
Angela, a 47-year-old resident of Athens, Georgia, has suffered from depression since childhood, with frequent thoughts of suicide. In the past 15 years, her doctors, who were not trained in psychiatry, prescribed approximately 20 different drugs. None were effective, and one antidepressant had serious side effects on her vision.
A Miller School of Medicine dermatologist offers guidance to physicians diagnosing and treating leg and foot ulcers in a collaborative article published October 19 in the New England Journal of Medicine. “Chronic lower-extremity wounds affect millions worldwide, and optimizing results through evidenced-based care can improve patient outcomes, restore healthy limbs and save lives,” said Robert S. Kirsner, M.D., Ph.D.
The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has received three important distinctions for the quality of its cancer registry data.
Attention Miller School of Medicine entrepreneurs: The University of Miami School of Business Administration is now accepting entries to the 2018 University of Miami Business Plan Competition, which will take place in April, 2018. The competition is open to all University of Miami students in good academic and financial standing during the current academic year.